Extrafacial Lentigo Maligna: A Clinical And Dermoscopic Analysis According to Localization.

dermoscopy lentigo maligna melanoma skin cancer

Journal

Dermatology practical & conceptual
ISSN: 2160-9381
Titre abrégé: Dermatol Pract Concept
Pays: Austria
ID NLM: 101585990

Informations de publication

Date de publication:
Feb 2022
Historique:
accepted: 30 08 2021
entrez: 28 2 2022
pubmed: 1 3 2022
medline: 1 3 2022
Statut: epublish

Résumé

Whether extrafacial lentigo maligna (EFLM) differs clinically and/or dermoscopically according to location has not been analyzed in depth. To evaluate clinical and dermoscopic characteristics regarding different localization in a series of EFLM. We conducted a retrospective analysis of clinical and dermoscopic characteristics of 69 histologically proven EFLM retrieved from the database of two private institutions. Of the 69 EFLM included in the study, 25 (36.2%) were located in posterior trunk (PT), 16 (23.2%) in anterior trunk (AT), 15 (21%) in upper extremities (UE), and 13 (18.8%) in lower extremities (LE). Mean diameter among localization were as follows: 14.3 mm in PT, 11.8 mm in AT, 14 mm in UE, and 10 mm in LE (p 0.44). The most frequent dermoscopic criteria were angulated lines and tan structureless areas (70%), followed by atypical pigment network (60%), both with similar distribution among groups. Angulated lines pattern was the most frequent global pattern, observed in 55% of cases. Tan structureless/granularity pattern and patchy peripheral pigmented islands pattern were seen in 15.6% and 11.6% cases, respectively. No statistically significant differences were observed in the distribution of global dermoscopic pattern in the different localizations. From the clinical point of view, EFLM did not differ in terms of patient's age and diameter regarding localization. Upon dermoscopy, we found no significant differences in the overall dermoscopic pattern in the different localizations.

Identifiants

pubmed: 35223179
doi: 10.5826/dpc.1201a35
pii: dp1201a35
pmc: PMC8824700
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e2022035

Informations de copyright

©2022 Salerni et al.

Déclaration de conflit d'intérêts

Competing interests: None.

Références

J Am Acad Dermatol. 2015 Jun;72(6):1027-35
pubmed: 25824275
Lancet Oncol. 2002 Mar;3(3):159-65
pubmed: 11902502
Arch Dermatol. 1983 Oct;119(10):831-5
pubmed: 6614952
Arch Dermatol. 2009 Jun;145(6):725-6
pubmed: 19528438
Arch Dermatol. 2001 Oct;137(10):1343-50
pubmed: 11594860
Dermatol Pract Concept. 2014 Jan 31;4(1):77-82
pubmed: 24520520
Clin Exp Dermatol. 2013 Aug;38(6):612-6
pubmed: 23837933
Clin Dermatol. 2002 May-Jun;20(3):276-8
pubmed: 12074867
Am J Pathol. 1969 Apr;55(1):39-67
pubmed: 5776171

Auteurs

Gabriel Salerni (G)

Dermatology Department, Hospital Provincial del Centenario de Rosario, Universidad Nacional de Rosario, Diagnóstico Médico Oroño, Rosario, Argentina.

Emilia Cohen-Sabban (E)

Dermatology Service, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, Argentina.

Horacio Cabo (H)

Dermatology Department, Universidad de Buenos Aires, Argentina.

Classifications MeSH